Charles Schwab
CBST

Charles Schwab’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Charles Schwab’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-170,494
Closed -$17.2M – 3121
2014
Q4 		$17.2M Buy
170,494
+12,464
+8% +$969K 0.03% 570
2014
Q3 		$10.5M Buy
158,030
+2,797
+2% +$184K 0.02% 792
2014
Q2 		$10.8M Buy
155,233
+4,063
+3% +$276K 0.02% 766
2014
Q1 		$11.1M Buy
151,170
+15,327
+11% +$1.14M 0.02% 726
2013
Q4 		$9.36M Buy
135,843
+2,640
+2% +$171K 0.02% 767
2013
Q3 		$8.67M Sell
133,203
-70,619
-35% -$4.27M 0.02% 729
2013
Q2 		$10.2M Buy
+203,822
New +$10M 0.02% 565

Charles Schwab's CBST Position: Q1 2015 in Review

Charles Schwab sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 170,494 shares — an estimated $17.2M sold.

Charles Schwab first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $17.2M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Charles Schwab reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Charles Schwab sold 170,494 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $17.2M.
  • Charles Schwab first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Charles Schwab's CUBIST PHARMACEUTICALS INC position peaked at $17.2M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Charles Schwab's 13F filing for Q1 2015, filed 14 May 2015.